# Contrast The Role of Avitene And OK-432 in Reducing Seroma Formation After Axillary Lymphadenectomy for Breast Cancer

> **NCT02158299** · PHASE4 · UNKNOWN · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 3 (estimated)

## Conditions studied

- Drainage
- Postoperative Complications

## Interventions

- **DRUG:** Avitene
- **DRUG:** Sapylin
- **BEHAVIORAL:** axillary drainage
- **OTHER:** reexamine

## Key facts

- **NCT ID:** NCT02158299
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2014-11
- **Final completion:** —
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2014-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02158299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02158299, "Contrast The Role of Avitene And OK-432 in Reducing Seroma Formation After Axillary Lymphadenectomy for Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02158299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*